Published in Pharma Investments, Ventures and Law Weekly, July 30th, 2006
Scientists in France report, "We present a case in which suicide was a severe neuropsychiatric reaction to treatment with mefloquine. Physicians must be aware of these serious psychiatric complications and bear them in mind when faced with atypical behavior or suspected suicide."
"The body of a 27-year-old man was discovered at his home, covered with multiple knife wounds," said Nathalie Jousset and colleagues at Centre Hospitalier Universitaire d'Angers. "The autopsy report concluded that death was due to a craniocerebral wound from a violent blow. Homicide was initially suspected. Suicide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly